And on heavy volume. This was/is a no-brainer. Nudge me when we're over 2. Nap time.
mgmt change and PcW needs to expand scope...
biotechs are valued on the cash they have, and the outlook for their potential products..almost none make money..they're burning 2.2mm a quarter so we're good for a year and a half..in the meantime, products are going to start to show rev this q, and you have all sorts of possibilities with the knr5500 i.e. partnerships, buyout, etc...if you don't think those are worth more than 10mm when there are biotechs out there with 20x that market cap with cash to only last 6 months and years away from approval or making money, then don't buy it. the big fears when buying biotech are 1) product won't get approval - that's not an issue here, at this time, and 2) the co. will run out of money. That issue has been taken care of
the stock went from 2.4 to 1.11 on the dilution..that's factored in..the only thing different is now they have 15.5 mm in cash (after q2). So you're paying 10mm for the co. Considering 2 prod on the mkt and one with ODD, i'd say that's extreeeeeeeemely cheap. Plus u keep talking about warrant conversiion, but that doesn't happen until maybe the high 1's...and then they'll have 20mm more in cash...there'll be 32 million shares out and they'll have 35 mm in cash...that's bad?
everyone was making a big deal that the short interest had increased last month....there were 12.5mm more shares out, so in relation to that, it was never any big deal
by preferred if ur referring to the warrants with the offering, that wouldn't happen til the stock were at lest 50 percent higher..so that's a nice gain...and when and if they didn't get converted, it would be another 11 mm shares - but another 20mm for dara....either way, there's no problem
all the ppl who wanted to sell early from the offering should be just about out. with this much new stock out and conv warrants at 1.67 (which realistically won't be converted til maybe 1.80) the stock will always need good volume to continue to climb, but will do so as it goes from weak hands to strong. ST target .230-2.50